AMEA

The first, FDA-approved, liquid CGP test
with guideline-recommended biomarkers.1-4

Fast turnaround time
with results in <7 days1,2

References

For the complete intended use statement including companion diagnostic indications,
please see the Guardant360 CDx Technical Information: Guardant360CDx.com/technicalinfo

Low reportable range
down to 0.001% MAF5

CGP, comprehensive genomic profiling; MAF, mutant allele fraction.